SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-019538
Filing Date
2019-07-12
Accepted
2019-07-12 16:25:32
Documents
1
Period of Report
2019-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3319
  Complete submission text file 0000899243-19-019538.txt   5401
Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Associates GP LLC (Reporting) CIK: 0001290166 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19953264

Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9005 2127058888
QVT Financial Investment Cayman Ltd. (Reporting) CIK: 0001771138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19953265